Schedule 13G ownership disclosure

CG oncology Inc

Security class unavailable · CUSIP: 156944100

Event date: 2024-01-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,958,810
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-045323
Form type
SC 13G/A
Filer
CG Oncology, Inc.
CIK
CIK 1991792
Filed
Apr 09, 2024
Reporting period
Jan 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub